Potassium Carbonate → HCID 135884575, compound
Reaction equation
[CH3:1][NH:2][CH2:3][C:4]1[NH:13][C:12](=[O:14])[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[N:5]=1.CCN(C(C)C)C(C)C.[CH3:24][O:25][C:26]1[CH:27]=[CH:28][C:29]2[NH:35][C:34](=[O:36])[N:33]([CH:37]3[CH2:42][CH2:41][N:40]([C:43]4[N:48]=[CH:47][N:46]=[C:45]([C:49](O)=[O:50])[CH:44]=4)[CH2:39][CH2:38]3)[CH2:32][CH2:31][C:30]=2[CH:52]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.C(=O)([O-])[O-].[K+].[K+]>CN(C=O)C>[CH3:1][N:2]([CH2:3][C:4]1[NH:13][C:12](=[O:14])[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[N:5]=1)[C:49]([C:45]1[CH:44]=[C:43]([N:40]2[CH2:41][CH2:42][CH:37]([N:33]3[CH2:32][CH2:31][C:30]4[CH:52]=[C:26]([O:25][CH3:24])[CH:27]=[CH:28][C:29]=4[NH:35][C:34]3=[O:36])[CH2:38][CH2:39]2)[N:48]=[CH:47][N:46]=1)=[O:50]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
2.3 mg (12 μmol) 2-methylaminomethyl-3H-quinazolin-4-one and 1.6 mg (12 μmol) DIPEA were placed in 350 μL DMF. 4.0 mg (10 μmol) of 6-[4-(7-methoxy-2-oxo-1,2,4,5-tetra-hydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-pyrimidine-4-carboxylic acid and 1.3 mg (10 μmol) DIPEA in 100 μL DMF were activated with 3.5 mg (11 μmol) TBTU in 50 μL DMF and then added dropwise. The reaction mixture was stirred overnight. 15 μL of an aqueous 2M potassium carbonate solution were added and the mixture was stirred for a further hour. The precipitate formed was allowed to settle and the supernatant solution was pipetted off and concentrated to dryness by rotary evaporation.
Workup
- additionadded dropwise
- stirringthe mixture was stirred for a further hour
- customThe precipitate formed
- concentrationconcentrated to dryness by rotary evaporation
Sources & evidence
- ORD record
- ord-5622097e9d7c46b4ab67a0babb637198
- Source dataset
- uspto-grants-2014_09
- Patent number
- US08829006B2
Reaction notes
Loading…